Aberdeen Group
GSK icon

Aberdeen Group’s GSK GSK Stock Holding History

Aberdeen Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-41,852
Closed -$1.79M – 959
2024
Q1 		$1.79M Hold
41,852
– – ﹤0.01% 786
2023
Q4 		$1.55M Buy
+41,852
New +$1.5M ﹤0.01% 794
2020
Q1 		– Sell
-253,440
Closed -$14.9M – 925
2019
Q4 		$14.9M Buy
253,440
+960
+0.4% +$53.4K 0.04% 383
2019
Q3 		$13.5M Hold
252,480
– – 0.03% 388
2019
Q2 		$12.6M Buy
+252,480
New +$12.7M 0.03% 459

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Aberdeen Group's GSK Position: Q2 2024 in Review

Aberdeen Group sold out of GSK (GSK) in Q2 2024, closing a stake of 41,852 shares — an estimated $1.79M sold.

Aberdeen Group first reported a position in GSK in Q2 2019 and held it in 5 quarters. The position peaked at $14.9M in Q4 2019. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • Aberdeen Group reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
  • Aberdeen Group sold 41,852 GSK shares in Q2 2024, an estimated $1.79M.
  • Aberdeen Group first reported a position in GSK in Q2 2019 and held it in 5 quarters.
  • Aberdeen Group's GSK position peaked at $14.9M in Q4 2019.
  • 884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Aberdeen Group's 13F filing for Q2 2024, filed 9 Aug 2024.